Gabay Avraham — SEC Form 4 filings
SEC reporting owner CIK 1777328. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-24.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-06-21 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 73,360 shares, $330,744 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 73,360 shares @ $4.51 ($330,744) in ORAMED PHARMACEUTICALS INC., filed 2026-07-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | Chief Financial Officer | 8 | — | 1 leg · 73,360 sh · $330,744 | 11 |
| Lifeward Ltd. (LFWD) | Director | 1 | — | — | 1 |
Form 4 filings — Gabay Avraham
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-24 | 4 | Lifeward Ltd. (LFWD) | Grant/award (A): 13,643 @ $0 | EDGAR |
| 2026-07-02 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Sale (S): 73,360 @ $4.51 | EDGAR |
| 2026-03-18 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 95,889 @ $0 | EDGAR |
| 2026-01-29 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Option exercise (M): 19,000 @ $0 · Option exercise (M): 19,000 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 81,216 @ $0 · Grant/award (A): 115,000 @ $0 · Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 34,000 @ $0 · Grant/award (A): 42,000 @ $0 | EDGAR |
| 2025-01-06 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 188,000 | EDGAR |
| 2024-11-08 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 30,000 | EDGAR |
| 2024-06-21 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 140,040 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1777328 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →